As of Dec 02
| -0.04 / -0.07%|
The 17 analysts offering 12-month price forecasts for ResMed Inc have a median target of 63.99, with a high estimate of 78.00 and a low estimate of 50.00. The median estimate represents a +7.51% increase from the last price of 59.52.
The current consensus among 21 polled investment analysts is to Buy stock in ResMed Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.